News search

E.g., 15/06/2025
E.g., 15/06/2025
Sarai Martínez Cano, Marcos Femenía Muiña, Elena Hernández, Vanessa Núñez, Manuel Rodrigo Tapias, Miguel Galán Burgos, Iñaki Robles,  Alberto Benguria, David Sancho y Almudena Ramiro
Research
2 Jun 2025

A team from the CNIC has discovered the key role of conventional type 1 dendritic cells (cDC1) in atherosclerosis and has developed an experimental therapy with immunosuppressive nanoparticles that slows the progression of the disease in animal models.

Jorge Nicolás Domínguez, Susana Temiño, Morena Raiola, Miquel Sendra y Miguel Torres.
Research
29 May 2025

CNIC researchers have discovered that the heart is formed from two independent cell types that act in synchrony from the onset of gastrulation. This finding could help to better understand the origin of certain congenital heart defects and open up new opportunities in regenerative medicine and tissue bioengineering.

Dr. Mariell Jessup
Research
14 May 2025

Dr. Mariell Jessup is Chief Science and Medical Officer of the American Heart Association

Juan Pablo Ochoa, Pablo García-Pavía, Laura Lalaguna, Marina López-Olañeta, María Arévalo-Núñez de Arenas y Enrique Lara-Pezzi.
Research
9 Apr 2025

A CNIC team has developed an innovative gene therapy strategy for arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5), a rare and deadly inherited condition that particularly affects young men

Enrique Lara-Pezzi, Laura Lalaguna, Benedetta Coppe, Nadia Mercader y María  Galardi-Castilla.
Research
2 Apr 2025

Scientists at the CNIC and the University of Bern have found that heart surgery in male mice early in life creates a "memory" passed down to the next generation. Published in Circulation, the study suggests that a parental history of heart surgery should be considered when evaluating cardiovascular health in descendants.

About the CNIC
18 Mar 2025

The CNIC has been allocated €405,625 for its involvement in GRACE, a project focused on developing innovative strategies to improve the detection and management of cardiovascular diseases.


Anagha Jagannathan, Carlos Real Jiménez, Laura Cádiz, Sofía Trigo Anca, Anabel Díaz-Guerra Priego, Miguel Fernández Tocino, Carlos Galán Arriola, Borja Ibáñez, Agustín Clemente Moragón, Sandra Gomez, Ana Devesa, Juan Rene Delgado Cornejo, Danielle Medina-Hernandez, Warren Alexander Skoza, Lucía Pilar López Palomar, Nico Hoffmann, Carlos Caballero Henares and Ángela Pollán García.
Research
4 Feb 2025

The study, published in JACC: CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves mitochondrial function, improves myocardial energetics, and prevents degenerative changes in heart structure

Gráfico explicativo
Research
20 Jan 2025

An international study led by Spanish research teams has identified how genetic factors can influence the severity of disease caused by SARS-CoV-2

From left to right: D. MacGrogan, B. Flores-Garza, T. González-Costa, V. Sebastián-Serrano,  J.L. de la Pompa, L. Méndez-Peralta, A. Pau-Navalón, A. Galicia-Martín, J. Santos-Cantador,  C. Relaño-Ruperez, M. Siguero-Álvarez
About the CNIC
12 Dec 2024

The new project, ‘The Placenta in Maternal and Fetal Cardiovascular Health and Disease’, aims to understand how the placenta influences cardiovascular health in mothers and their children, promising improvements in the prevention and treatment of related diseases

El Dr. Valentín Fuster recibe el Premio de la Sociedad Internacional de Aterosclerosis
About the CNIC
5 Dec 2024

The International Atherosclerosis Society recognizes the contributions to the understanding and treatment of atherosclerosis by the director of the National Center for Cardiovascular Research (CNIC) and president of the Mount Sinai Fuster Heart